Literature DB >> 15147298

GABAB receptors in Schwann cells influence proliferation and myelin protein expression.

Valerio Magnaghi1, Marinella Ballabio, Ilaria T R Cavarretta, Wolfgang Froestl, Jeremy J Lambert, Ileana Zucchi, Roberto C Melcangi.   

Abstract

The location and the role of gamma-aminobutyric acid type B (GABA(B)) receptors in the central nervous system have recently received considerable attention, whilst relatively little is known regarding the peripheral nervous system. In this regard, here we demonstrate for the first time that GABA(B) receptor isoforms [i.e. GABA(B(1)) and GABA(B(2))] are specifically localized in the rat Schwann cell population of the sciatic nerve. Using the selective GABA(B) agonist [i.e. (-)-baclofen] and the antagonists (i.e. CGP 62349, CGP 56999 A, CGP 55845 A), such receptors are shown to be functionally active and negatively coupled to the adenylate cyclase system. Furthermore, exposure of cultured Schwann cells to (-)-baclofen inhibits their proliferation and reduces the synthesis of specific myelin proteins (i.e. glycoprotein Po, peripheral myelin protein 22, myelin-associated glycoprotein, connexin 32), providing evidence for a physiological role of GABA(B) receptors in the glial cells of the peripheral nervous system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147298     DOI: 10.1111/j.0953-816X.2004.03368.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  27 in total

Review 1.  Neuroactive steroids: A therapeutic approach to maintain peripheral nerve integrity during neurodegenerative events.

Authors:  Emanuela Leonelli; Marinella Ballabio; Antonio Consoli; Ilaria Roglio; Valerio Magnaghi; Roberto C Melcangi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 2.  GABA receptor-mediated effects in the peripheral nervous system: A cross-interaction with neuroactive steroids.

Authors:  Valerio Magnaghi; Marinella Ballabio; Antonio Consoli; Jeremy J Lambert; Ilaria Roglio; Roberto C Melcangi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 3.  Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance.

Authors:  Kyung-Jin Kim; Phillip L Pearl; Kimmo Jensen; O Carter Snead; Patrizia Malaspina; Cornelis Jakobs; K Michael Gibson
Journal:  Antioxid Redox Signal       Date:  2011-04-10       Impact factor: 8.401

4.  Expression of functional γ-aminobutyric acid type A receptors in Schwann-like adult stem cells.

Authors:  Alessandro Faroni; Giorgio Terenghi; Valerio Magnaghi
Journal:  J Mol Neurosci       Date:  2012-01-04       Impact factor: 3.444

5.  Baclofen modulates the expression and release of neurotrophins in schwann-like adipose stem cells.

Authors:  Alessandro Faroni; Francesca Calabrese; Marco Andrea Riva; Giorgio Terenghi; Valerio Magnaghi
Journal:  J Mol Neurosci       Date:  2012-05-31       Impact factor: 3.444

6.  Progesterone derivatives increase expression of Krox-20 and Sox-10 in rat Schwann cells.

Authors:  Valerio Magnaghi; Marinella Ballabio; Ilaria Roglio; Roberto C Melcangi
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

7.  Effects of baclofen on motor units paralysed by chronic cervical spinal cord injury.

Authors:  Christine K Thomas; Charlotte K Häger-Ross; Cliff S Klein
Journal:  Brain       Date:  2009-11-10       Impact factor: 13.501

8.  GABA and neuroactive steroid interactions in glia: new roles for old players?

Authors:  Valerio Magnaghi
Journal:  Curr Neuropharmacol       Date:  2007-03       Impact factor: 7.363

Review 9.  GABA's control of stem and cancer cell proliferation in adult neural and peripheral niches.

Authors:  Stephanie Z Young; Angélique Bordey
Journal:  Physiology (Bethesda)       Date:  2009-06

10.  GABA increases electrical excitability in a subset of human unmyelinated peripheral axons.

Authors:  Richard W Carr; Ruth Sittl; Johannes Fleckenstein; Peter Grafe
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.